prednisone has been researched along with Cutaneous T-Cell Lymphoma in 60 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL)." | 9.09 | Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. ( Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C, 1999) |
| "Gemcitabine, a pyrimidine nucleoside analogue, is gaining recognition as a potential therapeutic agent for advanced-stage and refractory cutaneous T-cell lymphoma (CTCL)." | 8.91 | [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review]. ( Amoh, Y; Masuzawa, M; Takasu, H, 2015) |
| "In a pilot project 10 patients with advanced cutaneous T-cell lymphomas, who had received a variety of previous treatments, were treated with bexarotene at the departments of dermatology in Münster, Minden and Charité Berlin, Germany." | 7.72 | Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. ( Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W, 2003) |
| "This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL)." | 5.09 | Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. ( Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C, 1999) |
| "Gemcitabine, a pyrimidine nucleoside analogue, is gaining recognition as a potential therapeutic agent for advanced-stage and refractory cutaneous T-cell lymphoma (CTCL)." | 4.91 | [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review]. ( Amoh, Y; Masuzawa, M; Takasu, H, 2015) |
| "In a pilot project 10 patients with advanced cutaneous T-cell lymphomas, who had received a variety of previous treatments, were treated with bexarotene at the departments of dermatology in Münster, Minden and Charité Berlin, Germany." | 3.72 | Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. ( Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W, 2003) |
| "Subcutaneous panniculitis T-cell lymphoma (SPTCL) is a rare subtype of primary cutaneous lymphoma." | 2.45 | [Clinical analysis of 19 cases of subcutaneous panniculitis T-cell lymphoma with literature review]. ( Cai, MY; Huang, HQ; Huang, JJ; Li, ZM; Lin, TY; Ye, S, 2009) |
| "Biopsy of these areas revealed lobular panniculitis, lymphocytic infiltrate without cytological atypia, abundant lipophages and fibrosis and sclerosis consistent with a healing response." | 2.41 | Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis. ( Jarrett, P; Snow, J; Yung, A, 2001) |
| "In gastric MALT lymphoma, Helicobacter pylori might provide the antigenic stimulus for its growth." | 2.40 | [Recent progress in the management of malignant lymphoma]. ( Ohnishi, K, 1997) |
| "In many cases, SPTCL is accompanied by hemophagocytic syndrome (HPS), resulting in prominent systemic symptoms." | 1.35 | Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol. ( Bakhshi, S; Kumar, L; Kumar, R; Medhi, K; Rishi, A, 2008) |
| "To examine the association of OP with hematologic malignancies and to assess the clinical course of affected patients." | 1.34 | Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion. ( Daniels, CE; Markovic, SN; Myers, JL; Ryu, JH; Utz, JP, 2007) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of hematologic malignancy characterized by lesions in subcutaneous fat associated with systemic symptoms." | 1.34 | Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. ( Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P, 2007) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a very rare postthymic T-cell non-Hodgkin's lymphoma with poor prognosis." | 1.34 | Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy. ( Gupta, R; Huang, YW; Lipton, JF; Wang, JC; Zhang, H, 2007) |
| "Erythema nodosum was suspected and some transient improvement was obtained with intravenous antibiotics and glucocorticoids." | 1.33 | [Panniculitis in a 32-year-old man]. ( Hrycaj, P, 2006) |
| "Peripheral subcutaneous panniculitis-like T-cell lymphoma (PSPTCL) is a rare form of cutaneous lymphoma recently proposed as a distinct clinicopathological entity." | 1.32 | Cytotoxic gamma/delta subcutaneous panniculitis-like T-cell lymphoma: report of a case with pulmonary involvement unresponsive to therapy. ( Guizzardi, M; Hendrickx, IA; Mancini, LL; Monti, M, 2003) |
| "A biopsy of the initial panniculitis lesion demonstrated lobular panniculitis with a germinal center composed of benign mononuclear cells with a phenotype of CD4+CD45RO+CD5sCD3+ cCD3 epsilon + T-cell intracellular antigen-1 (TIA-1)- and granzyme B-." | 1.32 | Nasal-type natural killer cell lymphoma preceded by benign panniculitis arising in an asymptomatic HTLV-1 carrier. ( Adachi, A; Horikawa, T; Iwatsuki, K; Kunisada, M; Matsumoto, S; Ogawa, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (13.33) | 18.2507 |
| 2000's | 30 (50.00) | 29.6817 |
| 2010's | 19 (31.67) | 24.3611 |
| 2020's | 3 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, B | 2 |
| Li, K | 1 |
| Wang, H | 1 |
| Shen, X | 1 |
| Zheng, J | 1 |
| Bailey, CAR | 1 |
| Laurain, DA | 1 |
| Sheinbein, DM | 1 |
| Jones, HA | 1 |
| Compton, LA | 1 |
| Rosman, IS | 1 |
| Terui, H | 1 |
| Yamasaki, K | 1 |
| Yoshida, S | 1 |
| Aiba, S | 1 |
| Hotta, M | 1 |
| Yanagi, T | 1 |
| Sugai, T | 1 |
| Nakazato, S | 1 |
| Izumi, K | 1 |
| Hata, H | 1 |
| Okada, K | 1 |
| Goto, H | 1 |
| Matsuno, Y | 1 |
| Shimizu, H | 1 |
| Li, J | 2 |
| Zan, Y | 1 |
| Liu, H | 2 |
| Chen, L | 1 |
| Molinelli, E | 1 |
| Campanati, A | 1 |
| Brisigotti, V | 1 |
| Diotallevi, F | 1 |
| Radi, G | 1 |
| Racchini, S | 1 |
| Giangiacomi, M | 1 |
| Offidani, A | 1 |
| Garrido Colmenero, C | 1 |
| Arias Santiago, S | 1 |
| Blasco Morente, G | 1 |
| Martín Castro, A | 1 |
| Fujimoto, N | 1 |
| Kito, K | 1 |
| Yoshida, T | 1 |
| Tanaka, T | 1 |
| Lin, KW | 1 |
| Lee, YS | 1 |
| Phipps, C | 1 |
| Wang, L | 1 |
| Gao, T | 1 |
| Wang, G | 1 |
| Lloret-Ruiz, C | 1 |
| Molés-Poveda, P | 1 |
| Barrado-Solís, N | 1 |
| Gimeno-Carpio, E | 1 |
| Masuzawa, M | 1 |
| Takasu, H | 1 |
| Amoh, Y | 1 |
| Hou, S | 1 |
| Liu, X | 1 |
| Liu, J | 1 |
| Zhang, Z | 1 |
| Han, C | 1 |
| Punchak, M | 1 |
| Farahmand, A | 1 |
| Turegano, MM | 1 |
| Lazarus, ME | 1 |
| Hosler, GA | 1 |
| Liégeois, N | 1 |
| Anhalt, GJ | 1 |
| Moresi, JM | 1 |
| Medhi, K | 1 |
| Kumar, R | 1 |
| Rishi, A | 1 |
| Kumar, L | 1 |
| Bakhshi, S | 1 |
| O'Connor, OA | 1 |
| Savage, KJ | 1 |
| Nakahashi, H | 1 |
| Tsukamoto, N | 1 |
| Yamane, A | 1 |
| Saitoh, T | 1 |
| Uchiumi, H | 1 |
| Handa, H | 1 |
| Karasawa, M | 1 |
| Murakami, H | 1 |
| Kojima, M | 1 |
| Nojima, Y | 1 |
| Ballanger, F | 1 |
| Barbarot, S | 1 |
| Le Gouill, S | 1 |
| Gaillard, F | 1 |
| Cassagnau, E | 1 |
| Lodé, L | 1 |
| Dréno, B | 1 |
| Stalder, JF | 1 |
| Huang, JJ | 1 |
| Cai, MY | 1 |
| Ye, S | 1 |
| Li, ZM | 1 |
| Huang, HQ | 1 |
| Lin, TY | 1 |
| Kost Al, M | 1 |
| Kost Alová, M | 1 |
| Belada, D | 1 |
| Laco, J | 1 |
| Friedman, A | 1 |
| Abadi, M | 1 |
| Wu, K | 1 |
| Fisher, M | 1 |
| Abadi, J | 1 |
| Caudron, A | 1 |
| Bouaziz, JD | 1 |
| Battistella, M | 1 |
| Sibon, D | 1 |
| Lok, C | 1 |
| Leclech, C | 1 |
| Ortonne, N | 1 |
| Molinier-Frenkel, V | 1 |
| Bagot, M | 1 |
| Xie, JJ | 1 |
| Zhou, ZQ | 1 |
| Wang, Y | 1 |
| Li, Y | 1 |
| Zhang, RY | 1 |
| Ren, YB | 1 |
| Chen, B | 1 |
| Zhou, GY | 1 |
| Fernández-Morano, T | 1 |
| Aguilar-Bernier, M | 1 |
| Del Boz, J | 1 |
| Fúnez-Liébana, R | 1 |
| Gomez Vazquez, M | 1 |
| Navarra Amayuelas, R | 1 |
| Santos, M | 1 |
| Nogueira, L | 1 |
| Talahri, C | 1 |
| Massone, C | 1 |
| Cerroni, L | 1 |
| Mira, MT | 1 |
| Talhari, S | 1 |
| Intriago B, M | 1 |
| Peña O, C | 1 |
| Gray H, AM | 1 |
| Cabrera C, ME | 1 |
| Martínez C, V | 1 |
| Terada, T | 1 |
| Shirakashi, Y | 1 |
| Sugiura, M | 1 |
| Guizzardi, M | 1 |
| Hendrickx, IA | 1 |
| Mancini, LL | 1 |
| Monti, M | 1 |
| Kunisada, M | 1 |
| Adachi, A | 1 |
| Matsumoto, S | 1 |
| Ogawa, Y | 1 |
| Horikawa, T | 1 |
| Iwatsuki, K | 1 |
| Nguyen, NQ | 1 |
| Magro, CM | 1 |
| Crowson, AN | 1 |
| Byrd, JC | 1 |
| Soleymani, AD | 1 |
| Shendrik, I | 1 |
| Gutierrez, A | 1 |
| Rodriguez, J | 1 |
| Ramos, R | 1 |
| Gines, J | 1 |
| Sampol, A | 1 |
| Galmes, B | 1 |
| Besalduch, J | 1 |
| Marzano, AV | 1 |
| Vanotti, M | 1 |
| Boneschi, V | 1 |
| Gianelli, U | 1 |
| Alessi, E | 1 |
| Isogai, R | 1 |
| Kawada, A | 1 |
| Hashimoto, K | 1 |
| Aragane, Y | 1 |
| Tezuka, T | 1 |
| Maeda, Y | 1 |
| Kanamaru, A | 1 |
| Chattopadhyay, A | 1 |
| Slater, DN | 1 |
| Hancock, BW | 1 |
| Onesti, MG | 1 |
| Mazzocchi, M | 1 |
| De Leo, A | 1 |
| Scuderi, N | 1 |
| Bohmeyer, J | 1 |
| Stadler, R | 1 |
| Kremer, A | 1 |
| Nashan, D | 1 |
| Muche, M | 1 |
| Gellrich, S | 1 |
| Luger, T | 1 |
| Sterry, W | 1 |
| Liu, Z | 1 |
| Huang, C | 1 |
| Daniels, CE | 1 |
| Myers, JL | 1 |
| Utz, JP | 1 |
| Markovic, SN | 1 |
| Ryu, JH | 1 |
| Du-Thanh, A | 1 |
| Durand, L | 1 |
| Costes, V | 1 |
| Guillot, B | 1 |
| Dereure, O | 1 |
| Benbouzid, MA | 1 |
| Bencheikh, R | 1 |
| Benhammou, A | 1 |
| El Edghiri, H | 1 |
| Boulaich, M | 1 |
| Essakali, L | 1 |
| Kzadri, M | 1 |
| Di Mario, A | 1 |
| Garzia, M | 1 |
| d'Alò, F | 1 |
| Rumi, C | 1 |
| Massini, G | 1 |
| Bellesi, S | 1 |
| Zini, G | 1 |
| Rojnuckarin, P | 1 |
| Nakorn, TN | 1 |
| Assanasen, T | 1 |
| Wannakrairot, P | 1 |
| Intragumtornchai, T | 1 |
| Hrycaj, P | 1 |
| Zhang, H | 1 |
| Gupta, R | 1 |
| Wang, JC | 1 |
| Lipton, JF | 1 |
| Huang, YW | 1 |
| Keane, AM | 1 |
| Kasten, MJ | 1 |
| Zhang, Q | 1 |
| Nowak, I | 1 |
| Vonderheid, EC | 1 |
| Rook, AH | 2 |
| Kadin, ME | 1 |
| Nowell, PC | 1 |
| Shaw, LM | 1 |
| Wasik, MA | 1 |
| Fierro, MT | 2 |
| Doveil, GC | 1 |
| Quaglino, P | 2 |
| Savoia, P | 2 |
| Verrone, A | 2 |
| Bernengo, MG | 2 |
| Ohnishi, K | 1 |
| Koizumi, K | 1 |
| Sawada, K | 1 |
| Nishio, M | 1 |
| Katagiri, E | 1 |
| Fukae, J | 1 |
| Fukada, Y | 1 |
| Tarumi, T | 1 |
| Notoya, A | 1 |
| Shimizu, T | 1 |
| Abe, R | 1 |
| Kobayashi, H | 1 |
| Koike, T | 1 |
| Haycox, CL | 1 |
| Back, AL | 1 |
| Raugi, GJ | 1 |
| Piepkorn, M | 1 |
| Akpek, G | 1 |
| Koh, HK | 1 |
| Bogen, S | 1 |
| O'Hara, C | 1 |
| Foss, FM | 2 |
| Yung, A | 1 |
| Snow, J | 1 |
| Jarrett, P | 1 |
| Bacha, P | 1 |
| Osann, KE | 1 |
| Demierre, MF | 1 |
| Bell, T | 1 |
| Kuzel, T | 1 |
| McGinnis, KS | 1 |
| Shapiro, M | 1 |
| Junkins-Hopkins, JM | 1 |
| Smith, M | 1 |
| Lessin, SR | 1 |
| Vittorio, CC | 1 |
| Fishman, SJ | 1 |
| McCormick, CM | 1 |
| McBurney, EI | 1 |
7 reviews available for prednisone and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Topics: Acneiform Eruptions; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and ove | 2021 |
Familial lupus panniculitis: two cases, same diagnosis, what evolution?
Topics: Adult; Biomarkers; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydro | 2020 |
[Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2015 |
[Clinical analysis of 19 cases of subcutaneous panniculitis T-cell lymphoma with literature review].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2009 |
Two atypical cases of cutaneous gamma/delta T-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 2011 |
[Recent progress in the management of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin | 1997 |
Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2001 |
2 trials available for prednisone and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemothera | 1999 |
Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Dexamethasone; Diphtheria Toxin; Drug Hyp | 2001 |
51 other studies available for prednisone and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Systemic chemotherapy promotes HIF-1α-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Doxorub | 2020 |
Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplas | 2018 |
Case of peripheral T-cell lymphoma, not otherwise specified, presenting dyshidrosis-like eruptions as the first clinical manifestation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Different | 2017 |
Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Do | 2018 |
[Chronic ulcer in nasal vestibule].
Topics: Chronic Disease; Diagnosis, Differential; Female; Granuloma, Lethal Midline; Humans; Immunocompromis | 2014 |
Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Blotting, Southern; CD4 A | 2015 |
Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fema | 2014 |
Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Topics: CD8-Positive T-Lymphocytes; Child; Diagnosis, Differential; Epidermis; Female; Glucocorticoids; Huma | 2015 |
Diffuse systemic large B-cell lymphoma with secondary skin involvement.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; | 2015 |
A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Eyelid Neoplasms; | 2016 |
Cutaneous T-Cell Lymphoma in a Patient With Psoriasis.
Topics: Aged, 80 and over; Biopsy; Colchicine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Prednisone; Psoria | 2017 |
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone | 2008 |
Subcutaneous panniculitislike T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Humans; Lympho | 2008 |
At long last, it's finally 'T' time.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubici | 2008 |
Prognosis and primary therapy in peripheral T-cell lymphomas.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair | 2008 |
Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cyclophosph | 2009 |
Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin | 2009 |
Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; | 2009 |
An unusual ulcer in an 8-year-old girl.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Do | 2010 |
[Granulomatous slack skin with anaplastic large cell lymphoma: report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD2 Antigens; CD3 Complex; CD4 Antigens; Cycl | 2011 |
Cutaneous CD8+ T-cell infiltrates associated with human immunodeficiency virus.
Topics: Adenine; Alopecia; Anti-HIV Agents; Antigens, Differentiation, T-Lymphocyte; Antiretroviral Therapy, | 2012 |
Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cycl | 2012 |
Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
Topics: Acyclovir; Antimalarials; Antineoplastic Agents, Hormonal; Antiviral Agents; Brazil; Child; Chloroqu | 2013 |
[Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Fatal Outcome | 2012 |
T-cell lymphoma of the penis as the first manifestation of adult T-cell lymphoma/leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2012 |
Cytotoxic gamma/delta subcutaneous panniculitis-like T-cell lymphoma: report of a case with pulmonary involvement unresponsive to therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; | 2003 |
Nasal-type natural killer cell lymphoma preceded by benign panniculitis arising in an asymptomatic HTLV-1 carrier.
Topics: Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modalit | 2003 |
Subcutaneous T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph | 2003 |
Atypical lymphocytic lobular panniculitis.
Topics: Adipose Tissue; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Huma | 2004 |
Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2004 |
Nodal peripheral T-cell lymphoma with secondary granulomatous cutaneous involvement.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Follow-Up S | 2004 |
Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo | 2004 |
Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cyclophosphamide; Doxorubicin; Female; | 2005 |
T-cell lymphoma presenting as a rapidly enlarging tumor on the lower eyelid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eyelids; Human | 2005 |
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combine | 2003 |
Prednisone combined with interferon for the treatment of one case of generalized granulomatous slack skin.
Topics: Adult; Drug Therapy, Combination; Female; Granuloma; Humans; Interferon-gamma; Lymphoma, T-Cell, Cut | 2005 |
Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion.
Topics: Acute Disease; Adult; Aged; Biopsy; Bronchi; Cryptogenic Organizing Pneumonia; Diagnosis, Differenti | 2007 |
[Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cyclophosphamide; | 2006 |
[Cervicofacial cellulitis revealing cutaneous lymphomas].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Cyclophosphamide; Diagnosis, Diff | 2007 |
Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; CD | 2007 |
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cycl | 2007 |
[Panniculitis in a 32-year-old man].
Topics: Adult; Azathioprine; Diagnosis, Differential; Erythema Nodosum; Humans; Lipodystrophy; Lymphoma, T-C | 2006 |
Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Hu | 2007 |
39-year-old woman with fever and weight loss.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differen | 2008 |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Topics: Cell Membrane; Cyclosporine; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Janus Kinase 3; | 1996 |
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Al | 1997 |
Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide | 1997 |
Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation.
Topics: Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 1997 |
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1998 |
Denileukin diftitox for the treatment of panniculitic lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Diphth | 2002 |
Pulsed high-dose corticosteroids and melphalan as an alternative therapy for refractory cutaneous T-cell lymphoma.
Topics: Dexamethasone; Drug Therapy, Combination; Humans; Lymphoma, T-Cell, Cutaneous; Male; Melphalan; Midd | 1992 |